Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.3500
+0.0310 (9.72%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Turnstone Biologics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-70.84-55.2-30.8333.27
Depreciation & Amortization
1.842.83.91.39
Loss (Gain) From Sale of Assets
0.530.32--
Asset Writedown & Restructuring Costs
-1.580.5-
Loss (Gain) From Sale of Investments
-1.86-2.06-0.10.54
Stock-Based Compensation
3.684.226.422.61
Other Operating Activities
-0.820.117.022.31
Change in Accounts Receivable
0.198.53-2.01-2.37
Change in Accounts Payable
0.83-3.43.41-2.16
Change in Unearned Revenue
--19.31-53.1-81.94
Change in Income Taxes
----0.1
Change in Other Net Operating Assets
-0.98-3.75-6.260.81
Operating Cash Flow
-67.44-66.15-71.06-45.63
Capital Expenditures
-0.23-1.25-5.17-3.41
Sale of Property, Plant & Equipment
0.030.45--
Investment in Securities
78.76-27.3-9.760.06
Investing Cash Flow
78.56-28.09-14.93-3.35
Issuance of Common Stock
0.0477.940.160.34
Other Financing Activities
-0.03-0.9-2.81-
Financing Cash Flow
0.0177.05-2.6679.95
Net Cash Flow
11.13-17.2-88.6530.98
Free Cash Flow
-67.67-67.4-76.23-49.04
Free Cash Flow Margin
--349.12%-104.00%-48.41%
Free Cash Flow Per Share
-2.94-5.83-30.68-18.16
Cash Income Tax Paid
0.20.10.082.01
Levered Free Cash Flow
-40.89-45.82-31.3-
Unlevered Free Cash Flow
-40.89-45.82-31.3-
Change in Net Working Capital
0.3514.7621.07-
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q